Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MITO - Stealth BioTherapeutics receives Nasdaq non-compliance receipt

MITO - Stealth BioTherapeutics receives Nasdaq non-compliance receipt

Stealth BioTherapeutics Corp.
  • A clinical-stage biotechnology company, Stealth BioTherapeutics ( NASDAQ: MITO ) received a letter from Nasdaq on July 7, 2022 for not meeting with minimum bid price and market value of listed securities requirements.
  • Company requests an appeal, trading of the company's ADS will be suspended at the opening of business on July 18, 2022.
  • Shares +1.1% after hours

For further details see:

Stealth BioTherapeutics receives Nasdaq non-compliance receipt
Stock Information
Company Name: Stealth BioTherapeutics Corp.
Stock Symbol: MITO
Market: NYSE
Website: stealthbt.com
Menu
MITO MITO Quote MITO Short MITO News MITO Articles MITO Message Board
Get MITO Alerts

News, Short Squeeze, Breakout and More Instantly...